| References |
Endogenous peptide fragment. Induces vasorelaxation through release of NO and prostaglandins, perhaps through activation of a non-AT1, non-AT2 receptor, Mas. Counteracts the vasoconstrictive and proliferative effects of angiotensin II and stimulates vasopressin (anti-diuretic hormone) release in vivo.
参考相关：
A-779 1mg
|
Angiotensin III,human |
|
Angiotensin Converting Enzyme Inhibitor |
|
Angiotensin Ⅱ, human |
|
[Val5]-Angiotensin II acetate salt hydrate |
|
[Ile7] Angiotensin III |
|
Angiotensin III (human, mouse) |
|
Angiotensin II |
|
Angiotensin II |
|
Angiotensin I (human, mouse, rat) |
|
Angiotensin (1-7) |
|
Angiotensinogen (1-14), human |
|
[Ile7] Angiotensin III |
|
Angiotensin III, human |
|
Angiotensin II, human [Val5] |
|
Angiotensin II [Sar1] |
|
Angiotensin II [Sar1 Ile8] |
|
Angiotensin II (4-8), human |
|
Angiotensin II (3-8), human |
|
Angiotensin II (1-4), human |
|
Angiotensin II, human |
|
Angiotensin I, human |
|
Angiotensin I [Des-Asp1-], human |
|
Angiotensin Converting Enzyme Inhibitor |
|
Angiotensin, Canine, rat |
|
Angiotensin Acetate |
|
